Biotechnology company developing the MIMIX platform, a silk-based dissolvable microarray patch for needle-free, sustained-release delivery of vaccines and therapeutics
Biotechnology company developing the MIMIX platform, a silk-based dissolvable microarray patch for needle-free, sustained-release delivery of vaccines and therapeutics. The shelf-stable system is designed to improve treatment efficacy and access by reducing refrigeration and clinical-administration requirements, with applications including vaccines, mRNA, GLP-1 therapies, and immunotherapies.